dc.contributor.author | Ózsvári, László | |
dc.date.accessioned | 2021-03-16T12:29:56Z | |
dc.date.available | 2021-03-16T12:29:56Z | |
dc.date.issued | 2017-05 | |
dc.identifier.citation | Magyar Állatorvosok Lapja 139(5),271-275. (2017) | en_US |
dc.identifier.uri | http://hdl.handle.net/10832/2689 | |
dc.description.abstract | Summary
Background: Swine dysentery is an infectious disease that affects growing and
fattening pigs, causing severe bloody diarrhoea and haemorrhagic colitis, and
often occurs worldwide including Hungary. Swine dysentery cause significant
economic losses which are associated with high mortality and medication cost,
and poor average daily gain (ADG), feed conversion ratio (FCR) and lean meat
ratio after infection.
Objectives: The aim of the study was to briefly present the clinical symptoms
and the ways of prophylaxis of the disease with special regard to the effective
antibiotics, and to economically analyse the metaphylactic antibiotic treatment
of swine dysentery in Hungarian fattening pig herds.
Materials and Methods: Based on international literature data partial budget
calculation was used to assess the financial benefits of a 5 days long metaphy lactic antibiotic treatment of swine dysentery in a herd with 10,000 finishing
pigs by using average Hungarian production and price data of 2016.
Results and Discussion: The most effective prophylactic approach of swine
dysentery is to avoid the introduction of Brachyspira hyodysenteriae into the herd
by implementing good biosecurity measures. If the swine herd got infected with
the pathogen an effective metaphylactic treatment could greatly decrease the
detrimental production effects of the disease. In swine dysentery infected herds
an effective metaphylactic antibiotic treatment would result in 3.1% increase in
ADG, 28.5% decrease in mortality rate and 0.33% reduction in FCR on average
in the finishing phase compared to a herd without swine dysentery control. The
estimation predicts about €90,000 extra gross margin (income over feed cost)
on herd level in a year and more than €2.5 extra gross margin per finished pig.
If the treatment cost was less than €2.5 per finished pig the farmer would be
better off. | en_US |
dc.language.iso | hu | en_US |
dc.publisher | Magyar Állatorvosok Lapja | en_US |
dc.title | A sertésdizentéria elleni védekezés gazdasági jelentősége | en_US |
dc.title.alternative | Economic significance of swine dysentery control | en_US |
dc.type | Article | en_US |
dcterms.bibliographicCitation | Magyar Állatorvosok Lapja 139(5),271-275. (2017) | |